Unknown

Dataset Information

0

The Basement Membrane in a 3D Breast Acini Model Modulates Delivery and Anti-Proliferative Effects of Liposomal Anthracyclines.


ABSTRACT: Breast cancer progression is marked by cancer cell invasion and infiltration, which can be closely linked to sites of tumor-connected basement membrane thinning, lesion, or infiltration. Bad treatment prognosis frequently accompanies lack of markers for targeted therapy, which brings traditional chemotherapy into play, despite its adverse effects like therapy-related toxicities. In the present work, we compared different liposomal formulations for the delivery of two anthracyclines, doxorubicin and aclacinomycin A, to a 2D cell culture and a 3D breast acini model. One formulation was the classical phospholipid liposome with a polyethylene glycol (PEG) layer serving as a stealth coating. The other formulation was fusogenic liposomes, a biocompatible, cationic, three-component system of liposomes able to fuse with the plasma membrane of target cells. For the lysosome entrapment-sensitive doxorubicin, membrane fusion enabled an increased anti-proliferative effect in 2D cell culture by circumventing the endocytic route. In the 3D breast acini model, this process was found to be limited to cells beneath a thinned or compromised basement membrane. In acini with compromised basement membrane, the encapsulation of doxorubicin in fusogenic liposomes increased the anti-proliferative effect of the drug in comparison to a formulation in PEGylated liposomes, while this effect was negligible in the presence of intact basement membranes.

SUBMITTER: Wiedenhoeft T 

PROVIDER: S-EPMC7558514 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

The Basement Membrane in a 3D Breast Acini Model Modulates Delivery and Anti-Proliferative Effects of Liposomal Anthracyclines.

Wiedenhoeft Tabea T   Braun Tobias T   Springer Ronald R   Teske Michael M   Noetzel Erik E   Merkel Rudolf R   Csiszár Agnes A  

Pharmaceuticals (Basel, Switzerland) 20200919 9


Breast cancer progression is marked by cancer cell invasion and infiltration, which can be closely linked to sites of tumor-connected basement membrane thinning, lesion, or infiltration. Bad treatment prognosis frequently accompanies lack of markers for targeted therapy, which brings traditional chemotherapy into play, despite its adverse effects like therapy-related toxicities. In the present work, we compared different liposomal formulations for the delivery of two anthracyclines, doxorubicin  ...[more]

Similar Datasets

| S-EPMC3135851 | biostudies-other
| S-EPMC10239794 | biostudies-literature
| S-EPMC8394122 | biostudies-literature
| S-EPMC6451084 | biostudies-literature
| S-EPMC6603348 | biostudies-literature
| S-EPMC8070162 | biostudies-literature
| S-EPMC6877440 | biostudies-literature
| S-EPMC8484114 | biostudies-literature
| S-EPMC10731130 | biostudies-literature
| S-EPMC9295717 | biostudies-literature